Molinos Rio de la Plata S.A. (BCBA:MOLI)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	626,896	1,048,841	469,089	54,913	24,901	17,640
Market Cap Growth	-33.96%	123.59%	754.25%	120.52%	41.16%	52.30%
Enterprise Value	772,185	1,089,866	494,706	70,756	36,395	26,736
Last Close Price	3105.00	5210.00	2146.30	249.32	108.74	70.41
PE Ratio	-	32.09	4.66	2.15	4.52	6.69
Forward PE	-	23.32	23.32	12.62	9.29	11.67
PS Ratio	0.77	1.19	0.50	0.13	0.19	0.25
PB Ratio	1.91	3.47	1.31	0.39	0.66	0.95
P/TBV Ratio	2.19	3.95	1.45	0.44	0.78	1.15
P/FCF Ratio	-	-	2.05	1.41	2.25	6.03
P/OCF Ratio	-	-	1.88	1.24	2.02	4.43
PEG Ratio	-	1.14	1.14	1.14	1.14	1.14
EV/Sales Ratio	0.94	1.24	0.53	0.16	0.28	0.38
EV/EBITDA Ratio	-	-	5.84	2.91	3.91	6.14
EV/EBIT Ratio	-	-	8.27	5.94	7.20	13.24
EV/FCF Ratio	-28.64	-	2.17	1.81	3.28	9.14
Debt / Equity Ratio	0.54	0.42	0.36	0.44	0.64	0.99
Debt / EBITDA Ratio	-	149.99	1.53	2.54	2.60	4.21
Debt / FCF Ratio	-	-	0.57	1.58	2.18	6.27
Asset Turnover	1.23	1.24	1.71	2.02	1.71	1.55
Inventory Turnover	3.51	3.31	3.87	4.30	3.96	4.43
Quick Ratio	0.60	0.56	0.80	0.46	0.41	0.53
Current Ratio	1.22	1.40	1.66	1.49	1.35	1.33
Return on Equity (ROE)	-15.55%	9.88%	40.17%	28.44%	19.52%	18.19%
Return on Assets (ROA)	-5.20%	-1.72%	6.79%	3.50%	4.14%	2.82%
Return on Capital (ROIC)	-7.51%	-2.67%	10.80%	5.61%	6.39%	4.09%
Return on Capital Employed (ROCE)	-	-	12.10%	5.90%	8.40%	6.10%
Earnings Yield	-8.26%	3.12%	21.46%	46.49%	22.13%	14.94%
FCF Yield	-4.30%	-3.07%	48.68%	71.07%	44.51%	16.58%
Dividend Yield	13.08%	-	-	17.70%	-	9.17%
Payout Ratio	-	250.25%	52.46%	20.27%	61.41%	-
Buyback Yield / Dilution	-	-	0.21%	-	-	-
Total Shareholder Return	12.50%	-	0.21%	17.70%	-	9.17%

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.